Johnson & Johnson

JNJNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$641.804 B

$266.32 +0.28%

Close of 14 Sept 2026

Revenue

$94.2B

#39 by revenue

Earnings

$26.8B

#15 by earnings

Shares outstanding

2,409,898,597

Latest filing cover page

P/E ratio

23.9

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#1Eli Lilly & CoLLY$1.07T
#2Johnson & JohnsonJNJ$641.8B
#3AbbVieABBV$462.6B
#4Merck & Co.MRK$357.4B
#5NovartisNVS$265.2B

What if Johnson & Johnson were worth as much as…

Open the what-if tool →

Gold $29.9T

$12,394.11

Per share 46.5× higher

Bitcoin $1.56T

$648.19

Per share 2.43× higher

Nvidia $5.08T

$2,109.69

Per share 7.92× higher

Or at a round number

$1.00T $2.00T $5.00T $10.0T

Where these numbers come from

Share counts and financials for Johnson & Johnson are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 15 Sept 2026. Read the methodology.